Experience with long-term infliximab therapy in patients with ankylosing spondylitis
The duration of continuous use of infliximab is more than 8 years in patients with ankylosing spondylitis (AS). The efficiency of the drug persists in most patients during its long-term regular therapy. Objective. To evaluate the effectiveness and safety of long-term infliximab therapy in patients w...
Gorde:
| Egile Nagusiak: | , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Russo |
| Argitaratua: |
IMA PRESS LLC
2010-12-01
|
| Saila: | Научно-практическая ревматология |
| Gaiak: | |
| Sarrera elektronikoa: | https://rsp.mediar-press.net/rsp/article/view/951 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|